Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
9.01
+0.04 (0.45%)
At close: Dec 20, 2024, 4:00 PM
9.17
+0.16 (1.82%)
After-hours: Dec 20, 2024, 6:30 PM EST
Kura Oncology Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 701 | 1,068 | 847 | 932 | 2,157 | 623 | |
| Market Cap Growth | 121.18% | 26.07% | -9.08% | -56.80% | 246.14% | 16.68% | |
| Enterprise Value | 262 | 633 | 425 | 396 | 1,847 | 381 | |
| Last Close Price | 9.01 | 14.38 | 12.41 | 14.00 | 32.66 | 13.75 | |
| PB Ratio | 1.65 | 2.69 | 2.02 | 1.84 | 3.53 | 2.85 | |
| P/TBV Ratio | 3.53 | 2.69 | 2.02 | 1.84 | 3.53 | 2.85 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.03 | 0.01 | 0.02 | 0.04 | |
| Quick Ratio | 11.39 | 12.13 | 18.24 | 23.13 | 24.34 | 15.22 | |
| Current Ratio | 11.47 | 12.26 | 18.56 | 23.26 | 24.49 | 15.39 | |
| Return on Equity (ROE) | -46.28% | -37.34% | -29.31% | -23.35% | -21.60% | -33.25% | |
| Return on Assets (ROA) | -28.54% | -22.89% | -17.65% | -13.89% | -12.92% | -19.88% | |
| Return on Capital (ROIC) | -30.63% | -24.42% | -18.45% | -14.40% | -13.48% | -21.35% | |
| Earnings Yield | -28.20% | -14.29% | -16.03% | -14.00% | -4.16% | -10.13% | |
| FCF Yield | -24.15% | -11.70% | -13.07% | -11.34% | -3.34% | -8.79% | |
| Buyback Yield / Dilution | -18.20% | -9.31% | -0.96% | -25.01% | -26.54% | -19.20% | |
| Total Shareholder Return | -18.20% | -9.31% | -0.96% | -25.01% | -26.54% | -19.20% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.